Clinical Trial

National Database of Bone Metastases

Study acronym: BDMO
Recruiting
View on ClinicalTrials.gov →
Summary
BDMO is an Italian multicentre, observational, prospective study that collects data from all patients with bone metastases referred to each participating centre, using an on-line software 'tailor-made' for data collection.
Trial Details
NCT Number NCT06367491
Lead Sponsor Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Conditions Bone Metastases
Enrollment 800 participants
Start Date 2013-10-08
Primary Completion 2030-01-01 (estimated)
Study Completion 2030-01-01 (estimated)
Updated on ClinicalTrials.gov 2024-04-16